Skip to content
Finasteride Info

Finasteride Info

Emerging evidence & commentary on risks of finasteride as a treatment for hair loss

  • Home
  • Drug information
    • Overview
    • Drug labels
    • How finasteride was invented
    • The alliance – special section
    • Historical timeline
  • Weighing risks
    • Weighing the risks of taking finasteride
    • 5-alpha syndrome (post-finasteride syndrome)
    • Firsthand reports
    • Adverse event data
    • Doctors expressing concerns
  • Research
    • Research overview
    • 2020–present
    • Earlier research
      • 2015–2019
      • 2010–2014
      • 2000–2009
      • 1942–1999
    • By system & function
    • – 5-alpha syndrome (post-finasteride syndrome)
    • – Effects on fertility
    • Special topics
    • Clinical trials
    • Grey literature
    • Related research
    • History of research
  • Resources
    • Resources – main
    • Physicians expressing concerns
    • News & media coverage
    • Historical timeline
    • The alliance – special section
    • Regulatory activity
    • Legal matters
    • The Merck files
    • Posts archive
    • About this site
    • Search

REGULATORY ACTIVITY

Overview • United States • Canada • European Medicines Agency (EMA) • France • Germany • Sweden • United Kingdom • Australia & New Zealand • Japan • Korea • Document library • Posts

Japan: Pharmaceuticals and Medical Devices Agency (PMDA)

Review reports: Drugs

See Zagallo (dutasteride) at bottom of page

Many websites tout the benefits of finasteride for treating hair loss, while downplaying the risks. This site is different: it puts risks in the foreground, accompanied by supporting evidence. Learn more

  • Considering taking finasteride or dutasteride for hair loss? See Weighing the risks

Navigator

  • 5-alpha syndrome
  • Adverse event data
  • Drug information
  • Drug origins
  • Firsthand reports
  • Media coverage
  • Regulation
  • Research
  • Search site
  • Site index
  • Timeline
  • Weighing the risks

Most popular

  • Research on penile alterations
  • Weighing the risks
  • Huberman podcast
  • Impact on hormone signaling
  • Bad outcomes in clinical trials
  • Influencers raising alarms
  • Physician views
  • Adverse event data
  • How was finasteride invented?
  • Research by system & function

Categories

  • Adverse event reports (17)
  • Diagnosis & treatment (1)
  • Doctor views (11)
  • Firsthand experiences (18)
  • History & context (13)
  • Merck (16)
  • News (8)
  • Regulation & FDA (7)
  • Research (24)
Tweets by FinasterideInfo
  • Home
  • Drug information
  • Research
  • Posts archive
  • Site index
  • Search
  • About & contact
  • Medical Disclaimer

Recent Posts

  • Response to Dr. Ralph Trüeb’s writings on post-finasteride syndrome
  • Appendix: response to Trüeb
  • Seeking a medical sign of genital numbness
  • Mid-year update
  • The lost men: how Merck, GSK papered over bad outcomes in trials

Post categories

  • Adverse event reports (17)
  • Diagnosis & treatment (1)
  • Doctor views (11)
  • Firsthand experiences (18)
  • History & context (13)
  • Merck (16)
  • News (8)
  • Regulation & FDA (7)
  • Research (24)

© 2020–2023 Finasteride Info  •  Privacy Policy
This website is not a substitute for professional medical advice, diagnosis or treatment. See Medical Disclaimer